Newman, J. E., Paul, R. C., & Chambers, G. M. (2023). Assisted Reproductive Technology in Australia and New Zealand 2021. National Perinatal Epidemiology and Statistics Unit, UNSW Sydney. https://doi.org/10.26190/unsworks/30477
Newman JE, Paul RC, Chambers GM. Assisted Reproductive Technology in Australia and New Zealand 2021. National Perinatal Epidemiology and Statistics Unit, UNSW Sydney; 2023. doi:10.26190/unsworks/30477
Newman, Jade, et al. Assisted Reproductive Technology in Australia and New Zealand 2021. National Perinatal Epidemiology and Statistics Unit, UNSW Sydney, 2023.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.
RRM Academy Synopsis
Australia And New Zealand Performed 111,253 ART Cycles In 2021
This is a national registry report. The registry tracks outcomes among the 111,253 ART cycles performed at fertility clinics in Australia and New Zealand in 2021. Under age 30, about 40 in 100 own-egg fresh transfers ended in a baby. The rate fell to about 4 in 100 past age 44.
Study at a glance, national registry report of 111,253 ART cycles: 111,253 ART cycles were performed in Australia and New Zealand in 2021. Source: Newman JE et al., 2023, DOI 10.26190/unsworks/30477.
Key Findings
Clinics performed 111,253 ART cycles in 2021, 102,157 in Australia and 9,096 in New Zealand. Both counts rose from 2020, by 17.1% and 7.1%.
Own-egg fresh cycles, freeze-all cycles excluded, led to a live birth 15.5% of the time, or 25.3% once an embryo was transferred. Thawed cycles did better: 30.9% and 31.5%.
Among embryo transfers using a woman's own fresh eggs, 40.2% led to a live birth under age 30, compared with 3.7% after age 44.
Among 36,123 women who began ART in 2018 or 2019, 37.1% had a baby by their first full cycle. That share grew to 57% by the sixth full cycle.
Clinicians linked infertility to female factors alone in 39.4% of cycles, male factors alone in 15%, both partners in 13.1%, and 'unexplained' in 29.6% of 91,018 cycles by male-female couples.
Interpretation
ANZARD is a mandatory registry. Every accredited fertility clinic in Australia and New Zealand must report each cycle. This is a count of what happened in 2021. The registry cannot explain why any single cycle worked or failed. Clinicians assign each cause-of-infertility label themselves, and the report warns that definitions may vary between clinics. The 76% figure for six cycles is an estimate. The estimate assumes women who stopped treatment would have had a baby at the same rate as women who kept going, which the registry cannot confirm. Everyone counted here had already started treatment; the report says nothing about people who did not reach a clinic.
RRM Context
ANZARD counts ART cycles: IVF, ICSI, donor and thaw treatments together. The registry does not ask whether a couple's underlying cause of infertility was found before treatment began. Nearly three in ten cycles by male-female couples carried an 'unexplained' label, and the report cautions that definitions may vary between clinics. Restorative reproductive medicine looks for that cause first. Ovarian stimulation, egg retrieval and embryo transfer bypass the question. This registry measures how much treatment happens and how often it works.
Our editorial summary of this paper, not the article's abstract.
Key figures
Treatment activity, 2021
Measure
Value
Source
Total ART treatment cycles reported, New Zealand, 2021
8,861
Summary, ART treatment cycles
Share of ART treatments using the woman's own oocytes or embryos (autologous), 2021
93.1%
Summary
Total autologous ART cycles, 2021
8,247
ART treatment cycles chapter
Fresh cycles among autologous ART cycles, 2021
4,219 (51.2%)
ART treatment cycles chapter
Thaw cycles among autologous ART cycles, 2021
4,028 (48.8%)
ART treatment cycles chapter
Pregnancy and birth outcomes, 2021
Measure
Value
Source
Clinical pregnancy rate per ART treatment, 2021
28.8% (2,553)
Summary, Treatment outcomes
Birth rate per ART treatment, 2021
23.2% (2,059)
Summary, Treatment outcomes
Live birth rate per ART treatment, 2021
22.8% (2,021)
Summary, Treatment outcomes
Live birth rate per initiated autologous fresh cycle, excluding freeze-all cycles, 2021
20.9%
Clinical pregnancies and live births from autologous fresh cycles
Overall live birth rate per autologous fresh embryo transfer cycle, 2021
29%
Summary, Autologous fresh cycles
Live birth rate per autologous fresh embryo transfer cycle, women under 30, 2021
42.9%
Summary, Autologous fresh cycles
Overall live birth rate per autologous thaw embryo transfer cycle, 2021
34.9%
Summary, Autologous thaw cycles
Live birth rate per autologous thaw embryo transfer cycle, women under 30, 2021
41.8%
Summary, Autologous thaw cycles
Embryo transfer practice, 2021
Measure
Value
Source
Single embryo transfer share of autologous fresh embryo transfer cycles, 2021
96.8%
Summary, Autologous fresh cycles
Double embryo transfer share of autologous fresh embryo transfer cycles, 2021
3.2%
Summary, Autologous fresh cycles
Total frozen/thawed embryo transfer cycles, 2021
4,018
Summary, Autologous thaw cycles
Single embryo transfer share of frozen/thawed embryo transfer cycles, 2021
97.9%
Summary, Autologous thaw cycles
Double embryo transfer share of frozen/thawed embryo transfer cycles, 2021
2.1%
Summary, Autologous thaw cycles
Babies born and multiples, 2021
Measure
Value
Source
Total liveborn babies following ART, 2021
2,055
Summary
Total births following autologous and recipient cycles, 2021
2,038
Summary, Births by plurality
Multiple gestation share of births following autologous and recipient cycles, 2021
1.8%
Summary, Births by plurality
Upper bound on multiple gestation birth share across all maternal age groups, 2021
under 3%
Summary, Births by plurality
Cumulative live birth, women starting their first fresh autologous ART cycle in 2019 (followed to end of 2021)
Measure
Value
Source
Cohort size, women having their first fresh autologous cycle in 2019
1,958
Summary, Cumulative live birth rates
Cumulative live birth rate after one ART cycle, 2019 cohort
30.4%
Summary, Cumulative live birth rates
Cumulative live birth rate after two ART cycles, 2019 cohort
46.0%
Summary, Cumulative live birth rates
Cumulative live birth rate after five ART cycles, 2019 cohort
59.4%
Summary, Cumulative live birth rates
Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.